Hidradenitis Suppurativa in Pediatric Patients

Area of Science:

• Dermatology
• Pediatrics
• Inflammatory Disorders

Background:

• Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition affecting apocrine gland-rich areas.
• Prevalence in Western populations is up to 2%, with a notable and increasing incidence in pediatric patients.
• Nearly half of all HS cases report initial symptom onset during childhood.

Approach:

• This review synthesizes current knowledge on pediatric hidradenitis suppurativa.
• It examines epidemiology, clinical presentation, associated comorbidities, and therapeutic strategies.
• Barriers to timely diagnosis and the psychosocial burden on young patients are discussed.

Key Points:

• Pediatric hidradenitis suppurativa (HS) represents a significant portion of cases, often with early-onset symptoms.
• There is a recognized scarcity of dedicated clinical studies and evidence-based guidelines for pediatric HS.
• The review addresses diagnostic challenges and the profound physical and emotional effects on children and adolescents.

Conclusions:

• Early recognition and management of pediatric HS are crucial due to its chronic nature and potential for significant impact.
• Further research and development of specific pediatric guidelines are needed.
• Addressing diagnostic delays and the holistic well-being of affected children are paramount.